NCT07805928

Brief Summary

This prospective single-group study will evaluate a visual analog scale-guided multimodal analgesia algorithm during the first five days after posterior rib remodeling with osteosynthesis. Pain will be assessed at 6, 12, and 24 hours and every 12 hours thereafter through 120 hours. Treatment will be escalated or reduced according to prespecified pain tiers and safety rules. The primary outcome is the proportion of scheduled assessments with pain scores of 3 or lower. Protocol adherence, rescue treatment, medication exposure, and adverse events will also be measured.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2024Dec 2026

Study Start

First participant enrolled

January 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

September 8, 2026

Status Verified

September 1, 2026

Enrollment Period

1.9 years

First QC Date

September 1, 2026

Last Update Submit

September 1, 2026

Conditions

Keywords

RIBOSSRib RemodelingPostoperative PainVisual Analog ScaleMultimodal Analgesia;Elastomeric Pump

Outcome Measures

Primary Outcomes (1)

  • Proportion of Scheduled Pain Assessments With VAS 3 or Lower

    Number of protocol-scheduled assessments with pain intensity 0 to 3 on a 0-to-10 visual analog or numeric rating scale divided by the total number of completed scheduled assessments, reported overall and by postoperative time point.

    At 6, 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 hours after surgery. 1 day

Secondary Outcomes (4)

  • Five-Day Pain Burden

    From 6 hours through 120 hours after surgery, using scheduled assessments at 6, 12, 24, and every 12 hours thereafter. 5 days

  • Use of Rescue Analgesia or Regional Block

    From surgery through postoperative hour 120. 5 days

  • Cumulative Rescue Opioid Consumption

    From surgery through postoperative hour 120. 5 days

  • Incidence of Analgesia-Related Adverse Events

    From initiation of postoperative analgesia through postoperative hour 120. 5 days

Study Arms (1)

VAS-Guided RIBOSS Analgesia Algorithm

All participants receive algorithm-guided treatment. The active treatment tier changes according to scheduled VAS assessment and prespecified safety rules.

Procedure: VAS-Guided Multimodal Analgesia AlgorithmProcedure: Ultrasound-Guided Thoracic Wall Regional Block

Interventions

Proposed operational tiers: VAS 0-3, NSAID plus acetaminophen, optional magnesium or pregabalin, without PCA or mandatory block; VAS 4-5, base analgesia plus low-dose ketamine/NMDA strategy and elastomeric multimodal infusion, with optional regional block; VAS 6-10, base analgesia plus multimodal elastomeric infusion and mandatory rescue regional technique when not contraindicated. Reassessment occurs every 6 to 12 hours; treatment is reduced when VAS remains below 3 and escalated when VAS remains above 5. Exact drugs, doses, contraindications, and monitoring are specified in the final anesthesia appendix. Linked arm/group(s): VAS-Guided RIBOSS Analgesia Algorithm.

VAS-Guided RIBOSS Analgesia Algorithm

A paravertebral, erector spinae plane, serratus plane, epidural, or other approved block may be used according to the locked algorithm, anatomy, and anesthesia judgment. Technique, local anesthetic dose, and safety monitoring will be standardized. Linked arm/group(s): VAS-Guided RIBOSS Analgesia Algorithm.

VAS-Guided RIBOSS Analgesia Algorithm

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adults undergoing posterior aesthetic rib remodeling with osteosynthesis who receive the standardized postoperative analgesia algorithm.

You may qualify if:

  • Age 18 to 55 years.
  • Scheduled for posterior aesthetic rib remodeling with osteosynthesis using the standardized RIBOSS technique.
  • Ability to understand and use a 0-to-10 visual analog or numeric pain scale.
  • Availability for scheduled pain assessments through postoperative hour 120.
  • Written informed consent.

You may not qualify if:

  • Chronic opioid use or opioid use disorder requiring an individualized perioperative plan.
  • Contraindication to the base nonsteroidal anti-inflammatory drug or acetaminophen regimen and inability to use the predefined alternative pathway.
  • Contraindication to ketamine, lidocaine, dexmedetomidine, or the planned regional block when those components may be required.
  • Severe hepatic, renal, cardiac, neurologic, or psychiatric condition judged to make the algorithm unsafe.
  • Pregnancy or breastfeeding.
  • Inability to provide reliable pain scores or complete five-day monitoring.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica INO

Bogotá, Colombia

RECRUITING

Related Publications (4)

  • Aguilar Villa H, Villabona-Florez SJ, Hoyos AE, Perez Pachon ME, Serrano-Reyes HM, Diaz Sandoval CJ. Aesthetic Rib Cage Remodeling with Osteosynthesis: Body Structural High-Definition Reshaping (Rib Osteotomy with Osteosynthesis Stabilization). Plast Reconstr Surg. 2025 Feb 1;155(2):279-288. doi: 10.1097/PRS.0000000000011512. Epub 2024 May 6.

    PMID: 38710099BACKGROUND
  • Onate Valdivieso C, Onate Valdivieso D, Hoyos AE, Perez Pachon ME, Aguilar Villa H, Michels PJA, Viera A, Benavides JE, Villabona SJ, Ramirez B. Ultrasonic- and Ultrasound-assisted Improvement of Silhouette of the Torso: Bone Structure High-definition Remodeling (Part I). Plast Reconstr Surg Glob Open. 2024 Jan 10;12(1):e5513. doi: 10.1097/GOX.0000000000005513. eCollection 2024 Jan.

    PMID: 38204869BACKGROUND
  • Manzaneda Cipriani RM, Duran Vega H, Cala Uribe L, Viaro M, Adrianzen GA, Botelho DL. Waist Remodeling without Incision, with Ultrasound-guided Monocortical Fracture. Plast Reconstr Surg Glob Open. 2023 Dec 19;11(12):e5499. doi: 10.1097/GOX.0000000000005499. eCollection 2023 Dec.

    PMID: 38115833BACKGROUND
  • Aguilar HA, Hoyos AE, Ramirez B, Kazbek K, Viacheslav N, Villabona SJ, Serrano HM, Perez Pachon ME, Valdivieso DO, Valdivieso CO, Kazbek G, Proto R, Verdugo JP, Varela A. Global Survey on Rib Remodeling Techniques: Assessing Complications and Safety in Waistline Contouring. Plast Reconstr Surg Glob Open. 2026 Apr 13;14(4):e7609. doi: 10.1097/GOX.0000000000007609. eCollection 2026 Apr.

    PMID: 41983160BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Hugo Aguilar, MD, plastic surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hugo Aguilar, MD, Plastic surgeon

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Days
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2026

First Posted

September 8, 2026

Study Start

January 1, 2024

Primary Completion

December 12, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

September 8, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Not comtempled in the patient informed consent

Locations